Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective...

''We have received several additional reports of individuals in the 15-18 year age group being administered unapproved COVID-19 vaccines,'' the company said.

On reports that Covaxin booster doses were highly effective, he said this was yet to be fully studied as there were many cases of those who received both doses of Covaxin being affected by the virus.

Covaxin's booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US' Emory University, Bharat Biotech announced on Wednesday.

Tamil Nadu begins administering 'precaution dose' to 60+ age group, frontline workers

The third dose of Covaxin holds promise, the Indian Council of Medical Research said on Sunday just a day before the government plans to administer 'precaution' doses of COVID-19 vaccines to frontline...

The third dose of Covaxin holds promise, the Indian Council of Medical Research said on Sunday just a day before the government plans to administer 'precaution' doses of COVID-19 vaccines to frontline...

Bharat Biotech says its trial of Covaxin booster jabs has demonstrated long-term safety with no serious adverse events .

Covaxin received approval based on a thorough clinical trial evaluation for safety and immunogenicity in the 2-18 years age group. Currently, it is the only COVID-19 vaccine in India approved for...

Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.